Disease areas:
  • brain
Last updated:
Author(s):
Lynne Krohn, Francis P. Grenn, Mary B. Makarious, Jonggeol Jeffrey Kim, Sara Bandres-Ciga, Dorien A. Roosen, Ziv Gan-Or, Mike A. Nalls, Andrew B. Singleton, Cornelis Blauwendraat, International Parkinson's Disease Genomics Consortium
Publish date:
10 March 2020
Journal:
Neurobiology of Aging
PubMed ID:
32249012

Abstract

Multiple genes have been associated with monogenic Parkinson’s disease and Parkinsonism syndromes. Mutations in PINK1 (PARK6) have been shown to result in autosomal recessive early-onset Parkinson’s disease. In the past decade, several studies have suggested that carrying a single heterozygous PINK1 mutation is associated with increased risk for Parkinson’s disease. Here, we comprehensively assess the role of PINK1 variants in Parkinson’s disease susceptibility using several large data sets totalling 376,558 individuals including 13,708 cases with Parkinson’s disease and 362,850 control subjects. After combining these data, we did not find evidence to support a role for heterozygous PINK1 mutations as a robust risk factor for Parkinson’s disease.

Related projects

Neurodegenerative diseases (e.g. Alzheimer?s disease and Parkinson?s disease) are a major healthcare burden and the prevalence is predicted to increase significantly with the aging population.

Institution:
National Institute on Aging, United States of America

All projects